No attachments available.
Freeze Dried Plasma (FDP) Emergency Use Authorization or FDA Licensed Product
Contact and place of performance
Timothy Kelly
MD 21702
USA
Dept of Defense - Operational Medicine (OPMED) is seeking to procure either a Food and Drug Administration (FDA) licensed Freeze Dried Plasma product or a Freeze Dried Plasma product that has a current Emergency Use Authorization (EUA) from the FDA. OPMED is seeking potential industry partners who have a FDP product at this stage of development.
The Defense Health Agency (DHA), on behalf of Department of Defense Operational Medicine (OPMED), is conducting market research to identify potential industry partners capable of providing Freeze Dried Plasma (FDP). The agency requires a product that is either currently licensed by the Food and Drug Administration (FDA) or possesses a valid FDA Emergency Use Authorization (EUA). This sources sought notice is intended to locate suppliers who have reached these specific stages of product development to support operational medical requirements.
The procurement is identified under solicitation number HT9427-26-RFI-704 and is classified under NAICS code 325414 for Biological Product (except Diagnostic) Manufacturing and PSC 6515 for Medical and Surgical Instruments, Equipment, and Supplies. There is no set-aside designation assigned to this requirement. The primary place of performance is located in Maryland, and the primary point of contact for this notice is Timothy Kelly.
Responses to this inquiry are due by March 25, 2026. This notice was published on March 9, 2026, and last updated on March 10, 2026. No attachments are currently associated with this federal opportunity.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.